Frequency and Reasons for Non-Administration and Suspension of Drugs During an Acute Coronary Syndrome Event. The ERICO Study. [PDF]
Santos RCO +4 more
europepmc +1 more source
Seguimiento de los pacientes con secuelas no respiratorias de la COVID-19. [PDF]
Hernando JEC.
europepmc +1 more source
[Gemcitabine-induced digital necrosis in a patient with cervical squamous cell carcinoma: case report and literature review]. [PDF]
Guarín-Rivera S +4 more
europepmc +1 more source
Caracterización farmacológica de heparinas no convencionales
Descubierta por James McLean en 1916, la heparina, también conocida como heparina no fraccionada (HNF), ha sido utilizada desde la década de 1930. La HNF es aún un fármaco crucial para el tratamiento del tromboembolismo venoso (trombosis venosa profunda y el embolismo pulmonar), y los síndromes coronarios agudos; así como anticoagulante durante ...
openaire +1 more source
[Highlights of the 58th Congress of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)]. [PDF]
Peña-Otero D +8 more
europepmc +1 more source
Bivalirudina en trombocitopenia inducida por heparina
Montserrat Gasol-Boncompte +3 more
openaire +1 more source
[Diagnosis and Treatment of Pulmonary Embolism and Pulmonary Hypertension in Patients With Interstitial Lung Disease]. [PDF]
León-Román F +8 more
europepmc +1 more source
Inflammatory Response in Relation to COVID-19 and Other Prothrombotic Phenotypes. [PDF]
Páramo JA.
europepmc +1 more source

